Skip to main content
Marcus Keep, MD, Neurosurgery, Fargo, ND, Sanford Medical Center Fargo

MarcusKeepMDFAANS, FACS, FRCSC

Neurosurgery Fargo, ND

Neurosurgical Spine Surgery, Neurotrauma, Stereotactic & Functional Neurosurgery

Physician

Dr. Keep is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Keep's full profile

Already have an account?

Summary

  • Dr. Marcus Keep is a neurosurgeon in Fargo, ND. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 28 years. He also speaks multiple languages, including French and Spanish. He specializes in neurosurgical spine surgery, neurotrauma, and stereotactic & functional neurosurgery and is experienced in spine traumatology.

Education & Training

  • Section of Restorative Neurology, Lund University. Olle Lindvall, M.D., Ph.D., Lund, Sweden.
    Section of Restorative Neurology, Lund University. Olle Lindvall, M.D., Ph.D., Lund, Sweden.Research Fellow, Epilepsy, Parkinson's, Neuroprotection, 1994 - 1996
  • Montreal Neurological Institute, McGill University
    Montreal Neurological Institute, McGill UniversityResidency, Neurosurgery, 1989 - 1994
  • INSERM Unité 106  (Institut National de la Santé et de la Recherche Médicale), Laboratoire de Neuromorphologie. Constantino Sotelo, M.D., Ph.D. Hopital de la Salpetriere, Paris, France.
    INSERM Unité 106 (Institut National de la Santé et de la Recherche Médicale), Laboratoire de Neuromorphologie. Constantino Sotelo, M.D., Ph.D. Hopital de la Salpetriere, Paris, France.Research Fellow, Cerebellar transplantation, 1989 - 1990
  • Medical University of South Carolina
    Medical University of South CarolinaInternship, Surgery, 1988 - 1989
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1988

Certifications & Licensure

  • ND State Medical License
    ND State Medical License 2000 - 2024
  • PA State Medical License
    PA State Medical License 2003 - 2024
  • HI State Medical License
    HI State Medical License 1989 - 2024
  • WI State Medical License
    WI State Medical License 2001 - 2021
  • MT State Medical License
    MT State Medical License 2001 - 2014
  • CO State Medical License
    CO State Medical License 2007 - 2011
  • NM State Medical License
    NM State Medical License 2002 - 2008
  • American Board of Neurological Surgery Neurological Surgery
  • Royal College of Physicians and Surgeons of Canada (FRCSC)Fellow

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
  • Fellow (FAANS) American Association of Neurological Surgeons

Publications & Presentations

PubMed

Journal Articles

  • Minimally Invasive Subacute to Chronic Subdural Hematoma Evacuation with Angled Matchstick Drill and Repurposed Antibiotic Ventriculostomy Catheter Augmented with Alte...  
    James Dorosh , Marcus F. Keep, Cureus, 11/1/2019
  • Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival.  
    Munksgaard Thorén M, Chmielarska Masoumi K, Krona C, Huang X, Kundu S, Schmidt L, Forsberg-Nilsson K, Floyd Keep M, Englund E, Nelander S, Holmqvist B, Lundgren-Åkerlu..., Cancers, 4/25/2019

Professional Memberships

Other Languages

  • French, Spanish

Hospital Affiliations

Industry Relationships

  • Acting Chief Medical Officer, Mitochon Pharmaceuticals, Inc.Mitochon Pharmaceuticals is a private PA pharma developing treatments for severe neurological diseases, using a remarkable class of mitochondria-trophic drugs that reduce the mitochondria proton-gradient, thereby inducing BDNF, cAMP and preventing the formation of ROS. Huntington, MS and Parkinsons.Disclosure: I am acting Chief Medical Officer, and equity holder.2018 - Present
  • CEO, Maas Biolab, LLCMaas Biolab is developing a treatment for amyotrophic lateral sclerosis. Maas has FDA Orphan Drug Designation for Mitogard (r) cyclosporin to treat ALS.Disclosure: I am officer, board member, patentee and equity holder.1997 - Present
  • Member of the Board, NeuroVive Phamaceutical, ABNeuroVive Pharmaceutical is a biopharmaceutical company in Lund, Sweden developing NeuroSTAT(r) intravenous cyclosporin for traumatic brain injury, drugs for mitochondrial disorders, and hepatic diseases, including hepatitis B and C, and hepatocellular carcinoma.Disclosure: I was a founding member of the Board 2000- 2018. I am a shareholder.2000 - 2018